From a clinical perspective, up-regulation of ICAM-1 in the tumor microenvironment have been shown to be related to favorable prognosis among patients with various cancers, suggesting an enhancement in cancer immunosurveillance (113–115). The gene discussed is ICAM1; the disease is neoplasm.